Goldenwell Biotech (GWLL) Current Assets (2019 - 2020)

Goldenwell Biotech (GWLL) reported Current Assets of $250544.0 for Q3 2020, up 1.6% quarter-over-quarter from $246593.0 in Q4 2019.

Goldenwell Biotech (GWLL) Current Assets (2019 - 2020) Analysis & Trends

Goldenwell Biotech has reported Current Assets for 2 years, with the latest figure at $250544.0 in Q3 2020.

  • For the quarter ending Q3 2020, Current Assets changed N/A year-over-year to $250544.0; the trailing twelve-month figure through Sep 2020 stood at $250544.0 (changed N/A YoY), and the FY2019 full-year result was $246593.0, changed N/A from the prior year.
  • Current Assets for Q3 2020 stood at $250544.0, up from $246593.0 in the prior quarter.
  • The five-year high for Current Assets was $250544.0 in Q3 2020, with the low at $246593.0 in Q4 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Paranovus Entertainment Technology 75,216.52 Bn 75,216.52 Bn - 9.77 Mn
2 Kraft Heinz 26.76 Bn 22.68 Bn 2.22 Bn 10.68 Bn
3 General Mills 17.79 Bn 17.02 Bn 1.37 Bn 4.89 Bn
4 Jbs 13.93 Bn 9.37 Bn 2.32 Bn 17.62 Bn
5 Hormel Foods 13.00 Bn 12.16 Bn 518.51 Mn 3.49 Bn
6 Mccormick 12.70 Bn 13.10 Bn 708.90 Mn 2.61 Bn
7 Magnum Ice Cream 12.17 Bn 11.70 Bn - 3.67 Bn
8 J M Smucker 11.05 Bn 10.99 Bn 827.80 Mn 1.99 Bn
9 Smithfield Foods 10.57 Bn 9.49 Bn 511.00 Mn 5.03 Bn
10 Goldenwell Biotech - - 25,000.00 -

Historic Data

Download Data
DateValue
Sep 30, 2020 250,544.00
Dec 31, 2019 246,593.00